Jaw pain showdown: which injection works best?
NCT ID NCT07571265
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested three different injections for people with painful jaw arthritis: platelet-rich plasma (PRP), hyaluronic acid, and a steroid called triamcinolone acetonide. 64 adults received one of these or a placebo saline injection. Researchers measured pain and mouth opening after one week, one month, and three months to see which treatment worked best.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- platelet-rich plasma, hyaluronic acid, triamcinolone acetonide
- What this could lead to
- If one injection works best, it could offer a simple, non-surgical option for easing jaw arthritis pain.
- What could go wrong
- This is a small, single-center study with only 64 participants. Results may not apply to everyone, and any injection carries risks like infection or temporary discomfort.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
64 people
The number who actually took part.
- Started
-
May 2024
- Finished
-
Oct 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 50 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 1\. Patients with temporomandibular joint osteoarthritis with or without disc displacement. * 2\. Age ≥ 18 years \< 50 Exclusion Criteria: * 1\. Previous TMJ surgery * 2\. Medical history of blood-derived illness or any medication known to affect platelet function or concentration for a minimum of two weeks prior to treatment. * 3\. specific osteoarthritis like rheumatoid arthritis or psoriatic arthritis. * 4\. pregnant women or breastfeeding ones
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Temporomandibular arthritis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Faculty of Dentistry
Al Manyal, Cairo Governorate, 11553, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.